First identification of bla IMI-1in an Enterobacter cloacae clinical isolate from France

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 3, 2012, Pages 1664-1665

  Naas, Thierry ^a   Cattoen, Christian ^b   Bernusset, Stéphanie ^c   Cuzon, Gaelle ^c   Nordmann, Patrice ^c  

^a BICÊTRE HOSPITAL   (France)

^b CENTRE HOSPITALIER DE VALENCIENNES   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE DERIVATIVE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM; BLAIMI 1 PROTEIN; CARBAPENEM DERIVATIVE; CARBAPENEMASE; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; IMIPENEM; MEROPENEM; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; RNA 16S; TICARCILLIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BETA LACTAMASE; DRUG DERIVATIVE; PENICILLANIC ACID; PIPERACILLIN; TAZOBACTAM;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; CASE REPORT; ENTEROBACTER CLOACAE; FRANCE; GENE SEQUENCE; HUMAN; LETTER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKULL FRACTURE; TRACHEAL ASPIRATION PROCEDURE; TRAFFIC ACCIDENT; VENTILATOR ASSOCIATED PNEUMONIA; DNA SEQUENCE; DRUG EFFECT; ENTEROBACTERIACEAE INFECTION; GENETICS; ISOLATION AND PURIFICATION; MALE; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY;

ADULT; AMIKACIN; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTIONS; FRANCE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; PENICILLANIC ACID; PIPERACILLIN; PNEUMONIA, VENTILATOR-ASSOCIATED; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA;

EID: 84857155907     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.06328-11     Document Type: Letter

References (17)

1. Ambler RP, et al. 1991. A standard numbering scheme for the class A β-lactamases. Biochem. J. 276:269-270.
2. Aubron C, Poirel L, Ash Ronald J, Nordmann P. 2005. Carbapenemaseproducing Enterobacteriaceae, US rivers. Emerg. Infect. Dis. 11:260-264.
3. Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing; 19th informational supplement. CLSI document M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Lee EH, et al. 1991. Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high level resistance to imipenem. Antimicrob. Agents Chemother. 35:1093-1098.
5. Girlich D, Poirel L, Nordmann P. 2010. Novel ambler class A carbapenem-hydrolyzing beta-lactamase from a Pseudomonas fluorescens isolate from the Seine River, Paris, France. Antimicrob. Agents Chemother. 54:328-332.
6. Henriques I, Moura A, Alves A, Saavedra MJ, Correia A. 2004. Molecular characterization of a carbapenem-hydrolyzing classAbeta-lactamase,SFC-1, from Serratia fonticola UTAD54. Antimicrob. Agents Chemother. 48:2321-2324. (Pubitemid 38691642)
7. Kieser T. 1984. Factors affecting the isolation of CCC DNA from Streptomyces lividans and Escherichia coli. Plasmid 12:19-36. (Pubitemid 14046088)
8. Mollet C, Drancourt M, Raoult D. 1997. RpoB sequence analysis as a novel basis for bacterial identification. Mol. Microbiol. 26:1005-1011. (Pubitemid 27507884)
9. Naas T, Nordmann P. 1994. Analysis of a carbapenem-hydrolyzing class A β-lactamase from Enterobacter cloacae and of its LysR-type regulatory protein. Proc. Natl. Acad. Sci. U. S. A. 91:7693-7697. (Pubitemid 24238251)
10. Naas T, Vandel L, Sougakoff W, Livermore DM, Nordmann P. 1994. Cloning and sequence analysis of the gene for a carbapenem-hydrolyzing class A β-lactamase, Sme-1, from Serratia marcescens S6. Antimicrob. Agents Chemother. 38:1262-1270. (Pubitemid 24170705)
11. Naas T, Massuard S, Garnier F, Nordmann P. 2001. AmpD is required for regulation of expression of NmcA, a carbapenem-hydrolyzing β-lactamase of Enterobacter cloacae. Antimicrob. Agents Chemother. 45:2908-2915. (Pubitemid 32906691)
12. Nordmann P, Cuzon G, Naas T. 2009. The real threat of KPC carbapenemase-producing bacteria. Lancet Infect. Dis. 9:321-331.
13. Nordmann P, Naas T, Poirel L. 2011. Global spread of carbapenemaseproducing Enterobacteriaceae. Emerg. Infect. Dis. 17:1791-1798.
14. Poirel L, Le Thomas I, Naas T, Karim A, Nordmann P. 2000. Biochemical sequence analyses of GES-1, a novel class A extended-spectrum betalactamase, and the class 1 integron In52 from Klebsiella pneumoniae. Antimicrob. Agents Chemother. 44:622-632. (Pubitemid 30117952)
15. Queenan AM, Bush K. 2007. Carbapenemases: the versatile β-lactamases. Clin. Microbiol. Rev. 20:440-458.
16. Rasmussen BA, et al. 1996. Characterization of IMI-1 β-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae. Antimicrob. Agents Chemother. 40:2080-2086. (Pubitemid 26296251)
17. Yu YS, Du XX, Zhou ZH, Chen YG, Li LJ. 2006. First isolation of blaIMI-2 in an Enterobacter cloacae clinical isolate from China. Antimicrob. Agents Chemother. 50:1610-1611.